Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

573 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.
Baselga J, Swain SM. Baselga J, et al. Nat Rev Cancer. 2009 Jul;9(7):463-75. doi: 10.1038/nrc2656. Epub 2009 Jun 18. Nat Rev Cancer. 2009. PMID: 19536107 Review.
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.
Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Solé LA, Baselga J. Bellmunt J, et al. Cancer. 1997 Nov 15;80(10):1966-72. doi: 10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>;2-w. Cancer. 1997. PMID: 9366300 Clinical Trial.
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A, Albanell J, Solé-Calvo LA, Gallardo E, Bellmunt J, Vera R, Vidal R, Carulla J, Baselga J. Ribas A, et al. Cancer. 1998 Mar 1;82(5):878-85. Cancer. 1998. PMID: 9486577 Clinical Trial.
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
Felip E, Massuti B, Camps C, Benito D, Isla D, González-Larriba JL, López-Cabrerizo MP, Salamanca O, Puerto-Pica J, Moyano A, Baselga J, Rosell R. Felip E, et al. Clin Cancer Res. 1998 Nov;4(11):2723-8. Clin Cancer Res. 1998. PMID: 9829735 Clinical Trial.
The ErbB receptors as targets for breast cancer therapy.
Albanell J, Baselga J. Albanell J, et al. J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):337-51. doi: 10.1023/a:1018762216147. J Mammary Gland Biol Neoplasia. 1999. PMID: 10705918 Review.
Systemic therapy emergencies.
Albanell J, Baselga J. Albanell J, et al. Semin Oncol. 2000 Jun;27(3):347-61. Semin Oncol. 2000. PMID: 10864222 Review.
Type I receptor tyrosine kinases as targets for therapy in breast cancer.
Baselga J, Mendelsohn J. Baselga J, et al. J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):165-74. doi: 10.1023/a:1026355831693. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882302 Review.
Clinical trials of single-agent trastuzumab (Herceptin).
Baselga J. Baselga J. Semin Oncol. 2000 Oct;27(5 Suppl 9):20-6. Semin Oncol. 2000. PMID: 11049053 Review.
573 results
Jump to page